Fibromyalgia in Patient With Impaired Fasting Glucose

Objective: To assess the frequency of fibromyalgia among women with impaired fasting glucose.

Materials and Methods: The sample was selected from the patients who applied to the Internal Medicine clinic and whose fasting blood glucose level were ≥100 and <126 mg/dL in their routine examination [Group1 ] and patients whose fasting blood glucose were less than 100 constituted the control group [Group2 ]. Oral glucose tolerance test [OGTT ] has been applied to patients with impaired fasting glucose and whose 2nd hour OGTT levels were under 140 has been included. Patients were evaluated in terms of fibromyalgia according to modified 2010 ACR Fibromiyalgia Criteria. Functional status was assessed by using the Fibromyalgia Impact Questionnaire [FIQ ].

Inclusion criteria

• the study group subjects: fasting blood glucose level was between 100 and 126 mg/dL;
• the control group subjects: fasting blood glucose level was < 100 mg/dL.

Exclusion criteria

• Patients with a severe systemic disease (chronic kidney disease, liver disease etc. ),
• psychiatric disease,
• hypothyroidism or hyperthyroidism,
• any connective tissue disease
• patients who used medications that influenced the fibromyalgia symptoms, such as analgesics, antidepressants, and anticonvulsive medications